Literature DB >> 23886744

Angioarchitectural characteristics associated with complications of embolization in supratentorial brain arteriovenous malformation.

J Pan1, H He, L Feng, F Viñuela, Z Wu, R Zhan.   

Abstract

BACKGROUND AND
PURPOSE: Embolization is an important therapeutic technique in brain arteriovenous malformations; however, little has been reported on the factors contributing to complications. We retrospectively reviewed a large series of supratentorial brain AVMs to identify the angioarchitectural characteristics that might be associated with the complications of embolization and poor clinical outcomes.
MATERIALS AND METHODS: The clinical and angiographic features of 130 consecutive patients with supratentorial brain AVMs embolized with ethylene-vinyl alcohol copolymer in our hospital from 2005-2008 were retrospectively reviewed. None of these patients had prior embolization. Complications were classified as transient neurologic deficits, persistent neurologic deficits, and death. Univariate and multivariate analyses were conducted to assess the angiographic features in patients with and without complications.
RESULTS: Twenty-three complications occurred in 130 embolization procedures, 13 (10%) were transient neurologic deficits (9 ischemic and 4 hemorrhagic), 9 (6.92%) were persistent neurologic deficits (7 ischemic and 2 hemorrhagic), and 1 death occurred. By univariate analyses, eloquent cortex (OR, 2.57; 95% CI, 1.08-3.42) and exclusive deep venous drainage (OR, 4.56; 95% CI, 1.28-9.67) were correlated with procedural complications. The impaction of eloquent cortical location (P = .001) and exclusive deep venous drainage (P = .035) on complications were also demonstrated by multivariate analysis. Eloquent cortex mainly resulted in permanent ischemic neurologic deficit; occlusion of drainage vein was significantly correlated with periprocedural hemorrhage in supratentorial brain AVMs with subtotal and partial embolization.
CONCLUSIONS: In a retrospective study on supratentorial brain AVMs with first-time embolization, 6.92% of patients had permanent neurologic deficit or death. Eloquent cortical location and exclusive deep venous drainage were associated with complications.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23886744      PMCID: PMC7965765          DOI: 10.3174/ajnr.A3643

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  38 in total

1.  AHA Scientific Statement: Recommendations for the management of intracranial arteriovenous malformations: a statement for healthcare professionals from a special writing group of the Stroke Council, American Stroke Association.

Authors:  C S Ogilvy; P E Stieg; I Awad; R D Brown; D Kondziolka; R Rosenwasser; W L Young; G Hademenos
Journal:  Stroke       Date:  2001-06       Impact factor: 7.914

2.  Spetzler-Martin Grade III arteriovenous malformations: surgical results and a modification of the grading scale.

Authors:  Michael T Lawton
Journal:  Neurosurgery       Date:  2003-04       Impact factor: 4.654

3.  Risk of intracranial arteriovenous malformation rupture due to venous drainage impairment. A theoretical analysis.

Authors:  G J Hademenos; T F Massoud
Journal:  Stroke       Date:  1996-06       Impact factor: 7.914

4.  Combined endovascular embolization and surgery in the management of cerebral arteriovenous malformations: experience with 101 cases.

Authors:  F Viñuela; J E Dion; G Duckwiler; N A Martin; P Lylyk; A Fox; D Pelz; C G Drake; J J Girvin; G Debrun
Journal:  J Neurosurg       Date:  1991-12       Impact factor: 5.115

5.  Normal perfusion pressure breakthrough theory.

Authors:  R F Spetzler; C B Wilson; P Weinstein; M Mehdorn; J Townsend; D Telles
Journal:  Clin Neurosurg       Date:  1978

6.  Embolization of the nidus of brain arteriovenous malformations with n-butyl cyanoacrylate.

Authors:  G M Debrun; V Aletich; J I Ausman; F Charbel; M Dujovny
Journal:  Neurosurgery       Date:  1997-01       Impact factor: 4.654

7.  Risk of endovascular treatment of brain arteriovenous malformations.

Authors:  A Hartmann; J Pile-Spellman; C Stapf; R R Sciacca; A Faulstich; J P Mohr; H C Schumacher; H Mast
Journal:  Stroke       Date:  2002-07       Impact factor: 7.914

8.  Management of hemorrhagic complications from preoperative embolization of arteriovenous malformations.

Authors:  P D Purdy; H H Batjer; D Samson
Journal:  J Neurosurg       Date:  1991-02       Impact factor: 5.115

9.  The effect of embolization with N-butyl cyanoacrylate prior to surgical resection of cerebral arteriovenous malformations.

Authors:  J J Jafar; A J Davis; A Berenstein; I S Choi; M J Kupersmith
Journal:  J Neurosurg       Date:  1993-01       Impact factor: 5.115

10.  Multimodality treatment of giant intracranial arteriovenous malformations.

Authors:  Steven D Chang; Mary L Marcellus; Michael P Marks; Richard P Levy; Huy M Do; Gary K Steinberg
Journal:  Neurosurgery       Date:  2003-07       Impact factor: 4.654

View more
  1 in total

1.  Complications of Endovascular Treatments for Brain Arteriovenous Malformations: A Nationwide Surveillance.

Authors:  K Sato; Y Matsumoto; T Tominaga; T Satow; K Iihara; N Sakai
Journal:  AJNR Am J Neuroradiol       Date:  2020-03-19       Impact factor: 3.825

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.